Total knee replacement — known medically as total knee arthroplasty — has helped people overcome chronic knee pain and regain ...

Learn more Zimmer Biomet ZBH is set to release first-quarter 2026 results on April 28, before the market opens. The leading ...

CEO Greg Roche says ambulatory surgery centers have largely lacked access to robots for performing soft tissue procedures, ...

U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for ...

Stryker (SYK) shares fell 2% after Q1 earnings missed estimates at $2.60 EPS and $6.02B revenue, impacted by a March ...

Do you view any position(s) as a glaring need that must be addressed, or do the Jaguars have the luxury of taking a “best ...

Lower extremity orthopedic disorders, particularly degenerative diseases and related deformities, are a leading cause of pain and disability worldwide, ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including CONMED (NYSE:CNMD) and its peers. The ...

When robotic-assisted knee replacement technology began gaining traction, it was often framed as the next leap forward in orthopedic surgery, a tool promising greater precision, improved alignment and ...

Zimmer Biomet is off to a strong start to 2026 but stopped short of raising guidance for the year. Here's what the CEO had to ...

Zimmer Biomet saw a strong first quarter, and U.S. growth in particular was bolstered by the hip franchise, CEO Ivan Tornos said in an earnings call. “Our U.S. hip franchise grew 5% in the quarter as ...